Understanding U-100 Insulin Syringes: How Units Translate to Milligrams
The most critical concept when self-administering compounded tirzepatide at home is understanding that units on a syringe measure liquid volume (milliliters), not milligrams of active peptide:
- On any standard U-100 insulin syringe, 100 units = exactly 1.0 mL (milliliter).
- Therefore, 10 units = 0.10 mL, 25 units = 0.25 mL, and 50 units = 0.50 mL.
To determine how many units you must draw, your evaluating clinician and dispensing 503A pharmacy calibrate your liquid volume based on the total strength of the vial.
Master Tirzepatide Titration Chart: Units to Mg by Vial Concentration
Review the clinical dosing chart below. Find your prescribed milligram (mg) dose, locate your pharmacy’s vial concentration, and read the exact tick mark on your U-100 syringe:
| Titration Phase | Prescribed Dose (mg) | Standard Concentration (10 mg/mL) | High Concentration (20 mg/mL) | Injection Frequency |
|---|---|---|---|---|
| Weeks 1–4 (Initiation) | 2.5 mg | 25 units (0.25 mL) | 12.5 units (0.125 mL) | Once every 7 days |
| Weeks 5–8 (Therapeutic Tier 1) | 5.0 mg | 50 units (0.50 mL) | 25 units (0.25 mL) | Once every 7 days |
| Weeks 9–12 (Therapeutic Tier 2) | 7.5 mg | 75 units (0.75 mL) | 37.5 units (0.375 mL) | Once every 7 days |
| Weeks 13–16 (High Therapeutic) | 10.0 mg | 100 units (1.00 mL) | 50 units (0.50 mL) | Once every 7 days |
| Weeks 17–20 (Advanced Tier) | 12.5 mg | Requires 20 mg/mL vial | 62.5 units (0.625 mL) | Once every 7 days |
| Weeks 21+ (Maximum Maintenance) | 15.0 mg | Requires 20 mg/mL vial | 75 units (0.75 mL) | Once every 7 days |
Why the 4-Week Titration Schedule Is Medically Necessary
Tirzepatide stimulates both GLP-1 and GIP receptors. GLP-1 receptors in the stomach lining and central nervous system significantly slow down gastrointestinal motility. If a patient were to start directly at a therapeutic dose of 7.5 mg or 10 mg without building tolerance, they would likely suffer acute gastrointestinal distress, including intractable vomiting, dehydration, and severe cramping.
The mandatory 4-week titration intervals allow the smooth muscle of the stomach, your intestinal neuro-receptors, and your pancreas to gradually adapt:
- The 2.5 mg Initiation Phase (Weeks 1–4): Calibrates your gut microbiome and desensitizes peripheral nausea receptors while silencing obsessive food noise.
- The 5.0 mg Escalation Phase (Weeks 5–8): The first dose proven in clinical trials to generate statistically significant subcutaneous and visceral fat reduction.
- The 7.5 mg & 10.0 mg Phases (Weeks 9–16): Advanced metabolic acceleration for individuals targeting 15% to 20%+ total body fat loss.
Doctor-Prescribed Tirzepatide for $129/Month Flat Rate
No complex math or syringe confusion. Every vial is shipped with pre-labeled syringe markings, sterile supplies, and board-certified physician chart review. Flat $129/mo across all doses.
Check Your Clinical EligibilityStep-by-Step Injection Protocol: How to Draw and Administer
Administering your weekly subcutaneous injection is quick and virtually painless when following sterile clinical protocol:
- Cleanse the Vial Stopper: Take an alcohol prep pad and vigorously wipe the rubber top of your tirzepatide vial for 5 seconds. Allow it to air-dry.
- Equalize Pressure: Remove the needle cap from your syringe. Pull the plunger back to draw in air equal to your prescribed unit dose (e.g., 25 units of air for 25 units of liquid). Insert the needle into the rubber stopper and push the air into the vial.
- Invert and Draw Liquid: Invert the vial upside down with the needle inside. Slowly draw the plunger back until the top ring of the black plunger seal aligns perfectly with your prescribed unit line. Tap gently to dislodge any microscopic air bubbles.
- Select and Sanitize Injection Site: Choose a fatty area:
- Abdomen: At least 2 inches away from your belly button.
- Thigh: The front-middle or outer aspect of your upper thigh.
- Back of Upper Arm: Fatty tissue on the tricep area.
- Inject at 90 Degrees: Wipe the skin with an alcohol pad, let dry, pinch the fatty tissue gently, and insert the needle straight in at a 90-degree angle. Depress the plunger smoothly, wait 5 seconds, and withdraw the needle. Dispose of the syringe in an FDA-cleared sharps container.
Storage & Cold-Chain Stability Rules
Compounded tirzepatide is a fragile peptide chain that denatures if exposed to high heat or vigorous shaking:
- Refrigeration: Keep your vial stored in the refrigerator between 36°F and 46°F (2°C to 8°C). Never store it in the freezer or near freezer vents.
- Beyond-Use Date (BUD): Adhere strictly to the beyond-use date printed on your 503A pharmacy label. Multi-dose vials with bacteriostatic preservatives generally remain stable for 28 to 60 days once punctured.
- Visual Inspection: Prior to every injection, inspect the liquid. It should be crystal clear and colorless. If the solution appears cloudy, discolored, or contains visible floating particles, discard it immediately.
Frequently Asked Questions
Start Your Tirzepatide Protocol with Doctor Oversight
Experience the dual-incretin advantage with transparent flat-rate pricing. Complete our asynchronous clinical evaluation in under 5 minutes.
Start Your Free Clinical Intake